Contract HT942525C0035

Hemoglobin Oxygen Therapeutics Llc · Department Of Defense · May 22, 2025

Firm Fixed PriceSole SourceNAICS 541715

Hemoglobin Oxygen Therapeutics Llc was awarded a federal contract by Department Of Defense (Defense Health Agency) on May 22, 2025 for $9.56 million of work in research and development in the physical, engineering, and life sciences (except nanotechnology and biotechnology). Performance is in Souderton, PA. It was awarded under full and open competition. The contract has been modified 3 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on December 15, 2025.

Obligated to date
$9.56M
$9,559,948
Current value
$12.53M
Modifications
3
Latest December 15, 2025

Contract details

PIID
HT942525C0035
Award type
Definitive Contract
Pricing
Firm Fixed Price
Set-aside
No Set Aside Used.
Competition
Not Competed
NAICS
541715 · Research And Development In The Physical, Engineering, And Life Sciences (Except Nanotechnology And Biotechnology)
Product / service
Health R&D Services; Health Care Services; Experimental Development
Place of performance
Souderton, PA
First action
May 22, 2025
Latest action
December 15, 2025

Description

CANINE OXYGEN CARRIER MANUFACTURING RESTORATION AND REGULATORY ACTIVITIES

Modification timeline

  • December 15, 2025
    Mod P00003
    $819.9K
  • August 25, 2025
    Mod P00002
    $787.5K
  • July 10, 2025
    Mod P00001
    $500.0K
  • May 22, 2025
    Base award
    $7.45M

Similar contracts

RecipientAgencyDateObligated
Trenchant Analytics LlcDepartment Of DefenseDecember 31, 2025$250.0K
Viasat IncDepartment Of DefenseDecember 31, 2025$3.69M
Gemini Technical Services Jv, LlcDepartment Of DefenseDecember 31, 2025$5.84M
Ursa IncDepartment Of DefenseDecember 31, 2025$340.0K
The Johns Hopkins University Applied Physics Laboratory LlcDepartment Of DefenseDecember 31, 2025$5.68M
L3harris Forcex, Inc.Department Of DefenseDecember 31, 2025$2.39M

Top contractors in NAICS 541715

Lifetime obligated dollars across all federal contracts in this NAICS code.

Track this on BesaGov

Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.

✓ You’re on the list. We’ll never spam you.

Helpful guides

Continue learning

See all guides →
More on BesaGov

Keep researching

Track this contract, set alerts on similar opportunities, and build proposal pipelines on BesaGov.
Sign up free

Frequently asked questions

What is contract HT942525C0035?

Contract HT942525C0035 is a federal contract awarded to Hemoglobin Oxygen Therapeutics Llc by Department Of Defense on May 22, 2025 for $9.56 million of work classified under RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY). It has been modified 3 times since the base award.

Who won contract HT942525C0035?

Hemoglobin Oxygen Therapeutics Llc won contract HT942525C0035 from Department Of Defense.

How much is contract HT942525C0035 worth?

Contract HT942525C0035 has obligated $9.56 million to date, with a total potential value of $12.53 million if all options are exercised.